Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00020878
Status:
COMPLETED
Last Update Posted:
2020-08-03
First Post:
2001-07-11
Brief Title:
Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Jonsson Comprehensive Cancer Center
Study Overview
Official Title:
Celecoxib for Chemoprevention of Primary Lung Cancer
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer Celecoxib may be effective in preventing lung cancer in tobacco smokers
PURPOSE Phase II trial to study the effectiveness of celecoxib in preventing non-small cell lung cancer in tobacco smokers
PURPOSE Phase II trial to study the effectiveness of celecoxib in preventing non-small cell lung cancer in tobacco smokers
Detailed Description:
OBJECTIVES
Determine the efficacy and feasibility of celecoxib for chemoprevention of primary non-small cell lung cancer in high-risk tobacco smokers
Determine the safety and long-term side effects of this drug in this population
OUTLINE Patients receive oral celecoxib twice daily for 6 months
Patients are followed at 2 weeks and then at 6 months
PROJECTED ACCRUAL A total of 20 patients will be accrued for this study within 6 months
Determine the efficacy and feasibility of celecoxib for chemoprevention of primary non-small cell lung cancer in high-risk tobacco smokers
Determine the safety and long-term side effects of this drug in this population
OUTLINE Patients receive oral celecoxib twice daily for 6 months
Patients are followed at 2 weeks and then at 6 months
PROJECTED ACCRUAL A total of 20 patients will be accrued for this study within 6 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-G01-1966 | None | None | None |
| UCLA-0012067 | None | None | None |